DK164638C - Kombinationspraeparat af pyrimido-pyrimidiner og acetylsalicylsyre og/eller deres farmaceutisk acceptable salte, fremgangsmaade til dets fremstilling samt anvendelse af pyrimido-pyrimidiner og acetylsalicylsyre og/eller salte deraf sammen med farmaceutiske baerere til fremstilling af et kombinationspraeparat - Google Patents

Kombinationspraeparat af pyrimido-pyrimidiner og acetylsalicylsyre og/eller deres farmaceutisk acceptable salte, fremgangsmaade til dets fremstilling samt anvendelse af pyrimido-pyrimidiner og acetylsalicylsyre og/eller salte deraf sammen med farmaceutiske baerere til fremstilling af et kombinationspraeparat

Info

Publication number
DK164638C
DK164638C DK330585A DK330585A DK164638C DK 164638 C DK164638 C DK 164638C DK 330585 A DK330585 A DK 330585A DK 330585 A DK330585 A DK 330585A DK 164638 C DK164638 C DK 164638C
Authority
DK
Denmark
Prior art keywords
pyrimido
pyrimidines
asa
salts
prepare
Prior art date
Application number
DK330585A
Other languages
Danish (da)
English (en)
Other versions
DK164638B (da
DK330585A (da
DK330585D0 (da
Inventor
Klaus Ulrich Weithmann
Dirk Seiffge
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19853515874 external-priority patent/DE3515874A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK330585D0 publication Critical patent/DK330585D0/da
Publication of DK330585A publication Critical patent/DK330585A/da
Publication of DK164638B publication Critical patent/DK164638B/da
Application granted granted Critical
Publication of DK164638C publication Critical patent/DK164638C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK330585A 1984-07-21 1985-07-19 Kombinationspraeparat af pyrimido-pyrimidiner og acetylsalicylsyre og/eller deres farmaceutisk acceptable salte, fremgangsmaade til dets fremstilling samt anvendelse af pyrimido-pyrimidiner og acetylsalicylsyre og/eller salte deraf sammen med farmaceutiske baerere til fremstilling af et kombinationspraeparat DK164638C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3426961 1984-07-21
DE3426961 1984-07-21
DE19853515874 DE3515874A1 (de) 1984-07-21 1985-05-03 Kombinationspraeparat aus pyrimido-pyrimidinen und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung
DE3515874 1985-05-03

Publications (4)

Publication Number Publication Date
DK330585D0 DK330585D0 (da) 1985-07-19
DK330585A DK330585A (da) 1986-01-22
DK164638B DK164638B (da) 1992-07-27
DK164638C true DK164638C (da) 1992-12-14

Family

ID=25823162

Family Applications (1)

Application Number Title Priority Date Filing Date
DK330585A DK164638C (da) 1984-07-21 1985-07-19 Kombinationspraeparat af pyrimido-pyrimidiner og acetylsalicylsyre og/eller deres farmaceutisk acceptable salte, fremgangsmaade til dets fremstilling samt anvendelse af pyrimido-pyrimidiner og acetylsalicylsyre og/eller salte deraf sammen med farmaceutiske baerere til fremstilling af et kombinationspraeparat

Country Status (14)

Country Link
US (1) US4694024A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0169465B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS6143117A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE50497T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU574206B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1247529A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3576119D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK164638C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU193793B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE58612B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL75852A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ212797A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH22342A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT80837B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3508097A1 (de) * 1984-07-21 1986-02-06 Hoechst Ag, 6230 Frankfurt Kombinationspraeparat aus xanthinderivaten und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung
DE3627423A1 (de) * 1986-08-13 1988-02-18 Thomae Gmbh Dr K Arzneimittel enthaltend dipyridamol oder mopidamol und o-acetylsalicylsaeure bzw. deren physiologisch vertraegliche salze, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung der thrombusbildung
US4917896A (en) * 1986-08-15 1990-04-17 Nelson Research & Development Co. Penetration enhancers for transdermal delivery of systemic agents
DE3717337A1 (de) * 1987-05-22 1988-12-15 Hoechst Ag Verfahren zum nachweis der antiaggregatorischen wirkung von vasoaktiven stoffen, speziell von phosphodiesterase- und/oder cyclooxygenase-hemmern
AT393962B (de) * 1987-10-22 1992-01-10 Thomae Gmbh Dr K Synergistische arzneimittelkombination mit einem gehalt an einem phosphodiesterase-hemmer und derenverwendung
US5041430A (en) * 1989-09-18 1991-08-20 Du Pont Mereck Pharmaceutical Company Oral anticoagulant/platelet inhibitor low dose formulation
FR2681596B1 (fr) * 1991-09-23 1993-11-26 Thomas Andre Procede de preparation d'acetylsalicylates des bases puriques et pyrimidiques et de leurs nucleosides.
EP1093814A1 (en) * 1999-10-22 2001-04-25 Boehringer Ingelheim Pharma KG Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders
JP2002255155A (ja) * 2001-03-06 2002-09-11 Ricoh Elemex Corp 梱包材
US7064130B2 (en) * 2001-04-20 2006-06-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of radical-scavenging compounds for treatment and prevention of NO-dependent microcirculation disorders
RU2206316C1 (ru) * 2001-10-30 2003-06-20 Закрытое акционерное общество "ВЕРОФАРМ" Фармацевтическое средство сердечно-сосудистого действия
JP2006516593A (ja) * 2003-02-07 2006-07-06 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Mmp−9依存性疾患の治療及び予防のためのジピリダモール又はモピダモールの使用
WO2007092026A1 (en) * 2006-02-09 2007-08-16 Teva Pharmaceutical Industries Ltd. Dipyridamole extended-release formulations and process for preparing same
ITRM20060460A1 (it) * 2006-08-31 2006-11-30 Univ Roma Uso di acido acetil salicilico in combinazione con inibitori dei canali mrp4 per il trattamento di pazienti resistenti a detto acido acetil salicilico
US20100080846A1 (en) * 2008-09-25 2010-04-01 Avshalom Ben-Menachem Dipyridamole and acetylsalicylic acid formulations and process for preparing same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2368272A1 (fr) * 1976-10-20 1978-05-19 Theramex Compositions therapeutiques solides pour combattre l'agregation plaquettaire
LU77353A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1977-05-16 1979-01-19
DE3508097A1 (de) * 1984-07-21 1986-02-06 Hoechst Ag, 6230 Frankfurt Kombinationspraeparat aus xanthinderivaten und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung

Also Published As

Publication number Publication date
JPH0564615B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-09-16
PT80837B (pt) 1987-10-20
PH22342A (en) 1988-08-12
EP0169465B1 (de) 1990-02-28
DK164638B (da) 1992-07-27
DK330585A (da) 1986-01-22
IL75852A0 (en) 1985-11-29
PT80837A (de) 1985-08-01
IE58612B1 (en) 1993-10-20
JPS6143117A (ja) 1986-03-01
EP0169465A2 (de) 1986-01-29
HU193793B (en) 1987-11-30
CA1247529A (en) 1988-12-28
DE3576119D1 (de) 1990-04-05
HUT38255A (en) 1986-05-28
AU574206B2 (en) 1988-06-30
IE851821L (en) 1986-01-21
DK330585D0 (da) 1985-07-19
AU4519585A (en) 1986-01-23
EP0169465A3 (en) 1986-05-28
ATE50497T1 (de) 1990-03-15
NZ212797A (en) 1988-07-28
IL75852A (en) 1990-04-29
US4694024A (en) 1987-09-15

Similar Documents

Publication Publication Date Title
DK164638C (da) Kombinationspraeparat af pyrimido-pyrimidiner og acetylsalicylsyre og/eller deres farmaceutisk acceptable salte, fremgangsmaade til dets fremstilling samt anvendelse af pyrimido-pyrimidiner og acetylsalicylsyre og/eller salte deraf sammen med farmaceutiske baerere til fremstilling af et kombinationspraeparat
BR8800948A (pt) Solucao concentrada,composicao concentrada,processo para a preparacao de uma composicao polimerica e produto
BR8706723A (pt) Processo aperfeicoado,de dois estagios,para producao de acido acrilico
PT83862B (pt) Processo aperfeicoado para a producao de cerveja
DK298984A (da) Tetrahydropyridazinoner eller syreadditionssalte deraf, deres fremstilling og anvendelse som laegemidler samt mellemprodukter og disses fremstilling
MX163250B (es) Proceso para recuperar enzimas cristalinas
DK159119C (da) Analogifremgangsmaade til fremstilling af syreadditionssalte af 3alfa-acyloxy-2beta,16beta-dipiperidino-5alfa-androstanderivater samt fremgangsmaade til fremstilling af farmaceutiske oploesninger deraf
FI861655L (fi) Menetelmä lääkeaineina käyttökelpoisten griseoliinihapon johdannaisten valmistamiseksi
DK170986D0 (da) Substituerede 2,3,4,9-tetrahydro-1h-carbazol-1-eddikesyre-derivater, deres fremstilling og anvendelse som farmaceutika samt mellemprodukterved fremstillingen
PT89119A (pt) Processo para a preparacao de derivados de amidas aciclicas com actividade psicotropica
IT8421068A0 (it) Derivati di acido poliidrossibenzoico ad azione farmaceutica.
BR8907731A (pt) Processo para producao de acido hipocloroso,processo para producao de solucao de acido hipocloroso,processo para producao de solucoes concentradas de acido hipocloroso e solucao de acido hipoclorosohipocloroso
IT7920824A0 (it) Processo per la preparazione di acidi dienoici.
PT83269B (pt) Processo para a preparacao de derivados do acido 3-desmetil-mevalonico, de composicoes farmaceuticas que os contem bem como de intermediarios
BR7407275D0 (pt) Processo para a preparacao de derivados de acido carbonico do 2-mercapto-4 5-dicloro-tiazol bem como composicoes herbicidas a base destes
PT88116A (pt) Process for preparing naphthalenepropionic acid derivatives useful as anti-inflammatory/antiallergic agents
ES2021574B3 (es) Diester del acido alfa-tocoferol (halo) uridinafosforico, sus sales y metodos para producir el mismo.
PT87209A (pt) Processo para a producao de derivados de tiofeno uteis como produtos farmaceuticos
DK147784D0 (da) Substituerede piperazin-1-yl-eddikesyreamider,fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
FI881032A7 (fi) Menetelmä N-asetyyli-3 -fluorineuramiinihappojohdannaisten valmistamiseksi.
BR8005022A (pt) Processo para preparacao de estares de acido alfa-oxo-alfa-(3-alcoxicarbonil-2,2-dimetil-cicloroprop-1-il)-metano-fosfonico
FI892291A7 (fi) Menetelmä lääkeaineina käyttökelpoisten 6-fenoksimetyyli-4-hydroksitetrahydropyran-2-onien ja 6-tiofenoksimetyyli-4-hydroksitetrahydropyran-2-onien sekä vastaavien dihydroksikarboksyylihappojohdannaisten, suolojen ja estereiden valmistamiseksi
MX161373A (es) Procedimiento para la preparacion de las sales de adicion con acidos del 2-((2-amino etil)-tiometil)-5-dimetilaminometilfurano
BR8602725A (pt) Processo microbiologico para a preparacao de acido citrico
DK287686D0 (da) 3-hydroxy-3-(2-methyl-5-pyridyl)-propionsyrealkylestere samt deres fremstilling og anvendelse

Legal Events

Date Code Title Description
PBP Patent lapsed